I now have comprehensive information. Let me compile a thorough, well-organized answer.
Preeclampsia Management
Definition & Diagnosis Recap
Preeclampsia = new-onset hypertension (BP ≥140/90 mmHg on two occasions, ≥4 hours apart) after 20 weeks gestation, plus at least one of:
- Proteinuria (≥300 mg/24 hr, protein:creatinine ≥0.3, or dipstick 2+)
- Thrombocytopenia (<100,000/μL)
- Renal insufficiency (creatinine >1.1 mg/dL or doubling of baseline)
- Impaired liver function (transaminases ≥2× upper limit)
- Pulmonary edema
- New-onset headache unresponsive to medication / visual symptoms
Three Core Principles of Management
- Delivery is always appropriate therapy for the mother - but not always for the fetus. The only justification for delaying delivery is to allow fetal maturation.
- Treating the signs (BP, proteinuria) does not fix the pathology. Vasospasm and poor perfusion are the underlying drivers. Natriuresis can actually worsen fetal outcome by further reducing already-restricted plasma volume.
- Pathologic changes precede clinical diagnosis - irreversible fetal compromise can exist before criteria are met.
(Creasy & Resnik's Maternal-Fetal Medicine, p. 1069)
Part 1: Preeclampsia WITHOUT Severe Features
At Term (≥37 weeks)
- Prompt delivery is indicated. A Dutch RCT confirmed immediate induction = improved maternal outcome with similar neonatal outcomes.
Preterm (<37 weeks)
- Expectant management with:
- Antenatal corticosteroids
- Frequent maternal and fetal monitoring
- Serial BP checks, labs, fetal non-stress tests / BPP
- Bed rest (usually outpatient if stable)
Contraindications to expectant management:
- Persistent reversed end-diastolic flow in umbilical artery
- Abnormal fetal testing
- Fetal anomaly incompatible with survival
Part 2: Preeclampsia WITH Severe Features
Severe features are defined by ANY of:
- BP ≥160/110 mmHg on two readings ≥4 hrs apart
- Thrombocytopenia <100,000/μL
- Hepatic transaminases ≥2× upper limit, RUQ/epigastric pain
- Creatinine >1.1 mg/dL or doubling of baseline
- Pulmonary edema
- New-onset headache unresponsive to medication
- Visual disturbances
At Term (≥37 weeks) or Late Preterm (34-36+6 weeks)
- Deliver. Do not delay for corticosteroids, but can administer during induction if >12 hours anticipated.
Early Preterm (<34 weeks) - Expectant Management May Be Considered
Can extend pregnancy 5-19 days on average with close monitoring. Requires ICU-level or L&D monitoring.
Absolute contraindications to expectant management (deliver immediately after stabilization):
| Condition |
|---|
| Eclampsia |
| Pulmonary edema |
| DIC |
| Uncontrollable severe hypertension |
| Abnormal fetal testing / non-reassuring CTG |
| Placental abruption |
| Stillbirth |
| Non-viable fetus |
If none of the above: Give antenatal corticosteroids, monitor on L&D for 24-48 hrs with magnesium sulfate, then reassess. Delivery is then indicated if:
- HELLP syndrome develops
- Persistent neurological symptoms or RUQ pain
- Platelets <100,000/μL, transaminases >2× ULN, creatinine >1.1 mg/dL
- Reversed end-diastolic flow
- Labour or PROM
Part 3: Antihypertensive Therapy
Threshold for acute treatment: BP ≥160/110 mmHg (acute severe-range hypertension must be treated within 30-60 minutes to prevent maternal stroke/end-organ damage).
First-Line Acute Agents
| Drug | Dose | Route | Notes |
|---|
| Labetalol | 20 mg IV bolus, repeat 40 mg, then 80 mg q10 min (max 300 mg) | IV | Avoid in asthma, severe bradycardia |
| Hydralazine | 5-10 mg IV push, repeat q20-30 min | IV | Caution: reflex tachycardia, can cause maternal hypotension |
| Nifedipine | 10-20 mg oral, repeat in 20 min if needed | PO | Immediate-release; do NOT use sublingual |
For non-severe hypertension (140-159/90-109), antihypertensives are used for maternal safety but do not improve fetal outcome.
Maintenance Antihypertensives (chronic/outpatient)
- Labetalol 200-400 mg PO BID-TID
- Methyldopa 250-500 mg PO BID-TID (safe in pregnancy, minimal fetal effects)
- Nifedipine XL 30-60 mg PO daily
- Avoid: ACE inhibitors, ARBs (teratogenic/fetotoxic)
A 2024 network meta-analysis (PMID 38488570) found nifedipine and labetalol to be most effective with acceptable safety profiles for severe-range antihypertensive therapy in preeclampsia.
Part 4: Magnesium Sulfate - Seizure Prophylaxis & Treatment
Indications:
- Seizure prophylaxis in severe preeclampsia (during labor and for 24-48 hrs postpartum)
- Treatment of eclamptic seizures
Dosing (Standard Parkland Protocol)
- Loading dose: 4-6 g IV over 15-20 minutes
- Maintenance: 2 g/hr IV continuous infusion
- Continue 24-48 hours postpartum
Monitoring for Toxicity
| Finding | Serum Mg Level |
|---|
| Loss of deep tendon reflexes | ~10 mg/dL |
| Respiratory depression | ~12 mg/dL |
| Cardiac arrest | >15 mg/dL |
Monitor: DTRs hourly, urine output (>25 mL/hr), respiratory rate (>12/min)
Antidote: Calcium gluconate 1 g IV slow push reverses hypermagnesemia
(Rosen's Emergency Medicine, p. 3358)
Part 5: Fluid Management
- Restrict IV fluids - avoid aggressive hydration (risk of pulmonary edema)
- Target urine output >25 mL/hr
- Avoid diuretics unless pulmonary edema is present (diuretics worsen the already-contracted plasma volume)
- Avoid hyperosmotic agents
Part 6: Intrapartum Management
- Mode of delivery: Vaginal delivery is preferred; cesarean section reserved for standard obstetric indications
- Regional anesthesia (epidural) is preferred - helps BP control
- Continue magnesium sulfate throughout labor and 24 hrs postpartum
- Low threshold for continuous fetal monitoring
Part 7: Postpartum Management
- BP can worsen in the first 3-5 days postpartum - highest risk for eclampsia is 24-48 hrs after delivery
- Continue magnesium sulfate for 24-48 hours postpartum
- Treat BP ≥150/100 mmHg postpartum
- Oral options: labetalol, nifedipine XL, methyldopa
- A 2024 systematic review (PMID 39806714) supports oral antihypertensives over diuretics for postpartum hypertension management
- Counsel on long-term cardiovascular risk - preeclampsia is associated with 2× increased risk of heart disease and stroke later in life
Part 8: Eclampsia Management (Seizure)
Following the Parkland protocol:
- Airway, breathing, circulation - lateral decubitus position, supplemental O2
- Magnesium sulfate 4-6 g IV over 15-20 min, then 2 g/hr
- Control BP after seizure control if diastolic >105 mmHg
- Labs: CBC, platelets, LFTs, BUN, creatinine
- CT head if: altered consciousness, focal neurological signs, or seizures persist
- Deliver after maternal stabilization
If seizures persist despite MgSO4: lorazepam 2-4 mg IV, or phenytoin may be used as adjuncts.
Summary Decision Tree
Preeclampsia diagnosed
|
_____|______
| |
Without SF With SF
| |
≥37 wk → Deliver ≥34 wk → Deliver
<37 wk → Expectant <34 wk → Steroids + MgSO4 + Close monitoring
management → Reassess 48 hrs
+ steroids → Deliver if deterioration
Key: SF = Severe Features; MgSO4 = Magnesium Sulfate
Sources:
- Creasy & Resnik's Maternal-Fetal Medicine, pp. 1069-1072
- Rosen's Emergency Medicine, pp. 3357-3358
- Recent evidence: Anti-hypertensive therapy network meta-analysis [PMID 38488570, 2024]; Postpartum antihypertensives review [PMID 39806714, 2024]